ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
4 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
1.2K
|
313K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
3 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
1.2K
|
313K
|
3
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
imperatore
|
58 |
16K |
2 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
58
|
16K
|
2
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
imperatore
|
58 |
16K |
6 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
58
|
16K
|
6
|
|
ASX - By Stock
|
PER |
CMO interview not to be missed
|
|
imperatore
|
58 |
16K |
32 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
58
|
16K
|
32
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
imperatore
|
238 |
65K |
0 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
238
|
65K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
imperatore
|
238 |
65K |
3 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
238
|
65K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
3 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
1.2K
|
313K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
imperatore
|
238 |
65K |
6 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
238
|
65K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
imperatore
|
238 |
65K |
4 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
238
|
65K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
imperatore
|
238 |
65K |
5 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
238
|
65K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
imperatore
|
238 |
65K |
9 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
238
|
65K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Notification regarding unquoted securities - PER
|
|
imperatore
|
87 |
20K |
2 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
87
|
20K
|
2
|
|
ASX - By Stock
|
PER |
Re:
PER…..management needed..
|
|
imperatore
|
12 |
4.6K |
5 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
12
|
4.6K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
11 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
1.2K
|
313K
|
11
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
5 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
1.2K
|
313K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
5 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
1.2K
|
313K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
5 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
1.2K
|
313K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Will PER follow DXB on a similar journey ?
|
|
imperatore
|
47 |
13K |
5 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
47
|
13K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
5 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
1.2K
|
313K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
imperatore
|
157 |
39K |
2 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
157
|
39K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
imperatore
|
157 |
39K |
1 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
157
|
39K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
imperatore
|
157 |
39K |
2 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
157
|
39K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
imperatore
|
157 |
39K |
9 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
157
|
39K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
imperatore
|
157 |
39K |
5 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
157
|
39K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
imperatore
|
129 |
35K |
12 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
129
|
35K
|
12
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
imperatore
|
129 |
35K |
15 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
129
|
35K
|
15
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
imperatore
|
238 |
65K |
14 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
238
|
65K
|
14
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
imperatore
|
238 |
65K |
3 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
238
|
65K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron to present at 2024 BIO International Convention
|
|
imperatore
|
23 |
5.9K |
9 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
23
|
5.9K
|
9
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
imperatore
|
366 |
119K |
7 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
366
|
119K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
5 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
1.2K
|
313K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
imperatore
|
58 |
17K |
4 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
58
|
17K
|
4
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
imperatore
|
366 |
119K |
9 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
366
|
119K
|
9
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
imperatore
|
366 |
119K |
13 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
366
|
119K
|
13
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
imperatore
|
366 |
119K |
10 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
366
|
119K
|
10
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
3 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
1.2K
|
313K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
1.2K
|
313K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
1.2K
|
313K
|
6
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
1.2K
|
313K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
7 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
1.2K
|
313K
|
7
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
imperatore
|
366 |
119K |
3 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
366
|
119K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
4 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
1.2K
|
313K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
1.2K
|
313K
|
0
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
imperatore
|
1.2K |
313K |
8 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
1.2K
|
313K
|
8
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
imperatore
|
366 |
119K |
2 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
366
|
119K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
imperatore
|
115 |
32K |
4 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
115
|
32K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Open House Meeting
|
|
imperatore
|
25 |
6.1K |
11 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
25
|
6.1K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Open House Meeting
|
|
imperatore
|
25 |
6.1K |
5 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
25
|
6.1K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Open House Meeting
|
|
imperatore
|
25 |
6.1K |
4 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
25
|
6.1K
|
4
|
|